[
  {
    "ts": null,
    "headline": "Top Analyst Reports for Johnson & Johnson, Home Depot and Micron",
    "summary": "MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.",
    "url": "https://finnhub.io/api/news?id=54ec8bb96eae51196085e407fd1131601b698aa79b8d272456d673ee9cd3a2d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751488200,
      "headline": "Top Analyst Reports for Johnson & Johnson, Home Depot and Micron",
      "id": 135718046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.",
      "url": "https://finnhub.io/api/news?id=54ec8bb96eae51196085e407fd1131601b698aa79b8d272456d673ee9cd3a2d3"
    }
  },
  {
    "ts": null,
    "headline": "July Dog Of The Dow's 'Safer' Buy: Verizon",
    "summary": "Verizon Communications Inc. stands out as the top Dow dividend pick with strong cash flow and value potential. Click for my analysis and why I like VZ.",
    "url": "https://finnhub.io/api/news?id=8925dda184e2b9957f67d5da8f9ed43de30abb890049f9b7f766093e43a0a1fa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751476862,
      "headline": "July Dog Of The Dow's 'Safer' Buy: Verizon",
      "id": 135716420,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2181800802/image_2181800802.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Verizon Communications Inc. stands out as the top Dow dividend pick with strong cash flow and value potential. Click for my analysis and why I like VZ.",
      "url": "https://finnhub.io/api/news?id=8925dda184e2b9957f67d5da8f9ed43de30abb890049f9b7f766093e43a0a1fa"
    }
  },
  {
    "ts": null,
    "headline": "Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?",
    "summary": "JNJ is banking on Darzalex, Tremfya and new drugs to offset Stelara's LOE and Part D headwinds in Q2 Innovative Medicine sales.",
    "url": "https://finnhub.io/api/news?id=24cb13285fa35443fd672da62e4a29e62c4ac68bae73b5f24b0d49ebc1d4c128",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751461620,
      "headline": "Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?",
      "id": 135713902,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JNJ is banking on Darzalex, Tremfya and new drugs to offset Stelara's LOE and Part D headwinds in Q2 Innovative Medicine sales.",
      "url": "https://finnhub.io/api/news?id=24cb13285fa35443fd672da62e4a29e62c4ac68bae73b5f24b0d49ebc1d4c128"
    }
  },
  {
    "ts": null,
    "headline": "US FDA approves Regeneron's blood cancer therapy",
    "summary": "Regeneron Pharmaceuticalssaid on Wednesday the U.S. Food and Drug Administration hasapproved its drug for a type of blood cancer called multiplemyeloma that has recurred in patients who had...",
    "url": "https://finnhub.io/api/news?id=a84d7aa543d4a426e665e20d5c607299ff531d665f7ebac129c314c6c5467db9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751455509,
      "headline": "US FDA approves Regeneron's blood cancer therapy",
      "id": 135714921,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Regeneron Pharmaceuticalssaid on Wednesday the U.S. Food and Drug Administration hasapproved its drug for a type of blood cancer called multiplemyeloma that has recurred in patients who had...",
      "url": "https://finnhub.io/api/news?id=a84d7aa543d4a426e665e20d5c607299ff531d665f7ebac129c314c6c5467db9"
    }
  },
  {
    "ts": null,
    "headline": "Health Rounds:  3D printed insulin-producing cells show promise for type 1 diabetes in lab tests",
    "summary": "Insulin-producing human pancreascells can be manufactured with 3D printers, researchers reportedat the International Transplant Congress underway in London. Using a bio-ink made from...",
    "url": "https://finnhub.io/api/news?id=177f995937e63efd34eb99e088a7c6a00e8c2b599532c128268db324dd501c89",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751439708,
      "headline": "Health Rounds:  3D printed insulin-producing cells show promise for type 1 diabetes in lab tests",
      "id": 135710170,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Insulin-producing human pancreascells can be manufactured with 3D printers, researchers reportedat the International Transplant Congress underway in London. Using a bio-ink made from...",
      "url": "https://finnhub.io/api/news?id=177f995937e63efd34eb99e088a7c6a00e8c2b599532c128268db324dd501c89"
    }
  }
]